Jack W. Callicutt
2014
In 2014, Jack W. Callicutt earned a total compensation of $545.7K as Chief Financial Officer at Galectin Therapeutics, a 36% decrease compared to previous year.
Compensation breakdown
| Bonus | $38,500 |
|---|---|
| Option Awards | $293,402 |
| Salary | $175,000 |
| Other | $38,812 |
| Total | $545,714 |
Callicutt received $293.4K in option awards, accounting for 54% of the total pay in 2014.
Callicutt also received $38.5K in bonus, $175K in salary and $38.8K in other compensation.
Rankings
In 2014, Jack W. Callicutt's compensation ranked 9,986th out of 13,032 executives tracked by ExecPay. In other words, Callicutt earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,986 out of 13,032 | 23rd |
Division Manufacturing | 3,788 out of 4,965 | 24th |
Major group Chemicals And Allied Products | 1,304 out of 1,690 | 23rd |
Industry group Drugs | 1,043 out of 1,369 | 24th |
Industry Pharmaceutical Preparations | 799 out of 1,042 | 23rd |
Source: SEC filing on November 7, 2017.
Callicutt's colleagues
We found three more compensation records of executives who worked with Jack W. Callicutt at Galectin Therapeutics in 2014.